Search research articles
Contact Us
Filters
Showing results (111-120 of 166) with videos related to
Page
of 17
Sort By:
Blood Advances
|
January 11, 2022
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma
Loretta J Nastoupil, Collin K Chin, Jason R Westin, et al.
The Journal of Investigative Dermatology
|
December 10, 2021
miR-181a Promotes Multiple Protumorigenic Functions by Targeting TGFβR3
Vida Chitsazzadeh, Tran N Nguyen, Alvaro de Mingo Pulido, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 7, 2017
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection
Satyajit Kosuri, Tara Wolff, Sean M Devlin, et al.
Blood
|
February 10, 2019
Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma
Junling Zhuang, Fazal Shirazi, Ram Kumar Singh, et al.
British Journal of Haematology
|
March 18, 2020
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma
Nathan H Fowler, Loretta Nastoupil, Sven De Vos, et al.
Leukemia
|
June 15, 2021
Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML
Yuki Nishida, Ran Zhao, Lauren E Heese, et al.
Blood
|
June 25, 2017
Tonic B-cell receptor signaling in diffuse large B-cell lymphoma
Ondrej Havranek, Jingda Xu, Stefan Köhrer, et al.
Leukemia & Lymphoma
|
August 9, 2021
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma
Loretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, et al.
Blood Advances
|
October 14, 2022
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
Warren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, et al.
Blood
|
March 7, 2014
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance
Rodrigo Jacamo, Ye Chen, Zhiqiang Wang, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 166) with videos related to
Sort By:
Page
of 17
Blood Advances
|
January 11, 2022
Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma
Loretta J Nastoupil, Collin K Chin, Jason R Westin, et al.
The Journal of Investigative Dermatology
|
December 10, 2021
miR-181a Promotes Multiple Protumorigenic Functions by Targeting TGFβR3
Vida Chitsazzadeh, Tran N Nguyen, Alvaro de Mingo Pulido, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 7, 2017
Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection
Satyajit Kosuri, Tara Wolff, Sean M Devlin, et al.
Blood
|
February 10, 2019
Ubiquitin-activating enzyme inhibition induces an unfolded protein response and overcomes drug resistance in myeloma
Junling Zhuang, Fazal Shirazi, Ram Kumar Singh, et al.
British Journal of Haematology
|
March 18, 2020
The combination of ibrutinib and rituximab demonstrates activity in first-line follicular lymphoma
Nathan H Fowler, Loretta Nastoupil, Sven De Vos, et al.
Leukemia
|
June 15, 2021
Inhibition of translation initiation factor eIF4a inactivates heat shock factor 1 (HSF1) and exerts anti-leukemia activity in AML
Yuki Nishida, Ran Zhao, Lauren E Heese, et al.
Blood
|
June 25, 2017
Tonic B-cell receptor signaling in diffuse large B-cell lymphoma
Ondrej Havranek, Jingda Xu, Stefan Köhrer, et al.
Leukemia & Lymphoma
|
August 9, 2021
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K β/δ in relapsed refractory B cell lymphoma
Loretta J Nastoupil, Sattva S Neelapu, Richard Eric Davis, et al.
Blood Advances
|
October 14, 2022
Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia
Warren B Fingrut, Boglarka Gyurkocza, Jessica Flynn, et al.
Blood
|
March 7, 2014
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-κB mediates chemoresistance
Rodrigo Jacamo, Ye Chen, Zhiqiang Wang, et al.
Page
of 17